Instadose Pharma (Instadose Pharma) Interest Expense : $0.00 Mil (TTM As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Instadose Pharma's interest expense for the three months ended in Feb. 2022 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2022 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Instadose Pharma's Operating Income for the three months ended in Feb. 2022 was $ -0.89 Mil. Instadose Pharma's Interest Expense for the three months ended in Feb. 2022 was $ 0.00 Mil. GuruFocus does not calculate Instadose Pharma's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Instadose Pharma Interest Expense Historical Data

The historical data trend for Instadose Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Interest Expense Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Interest Expense

Get a 7-Day Free Trial

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Instadose Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Instadose Pharma (OTCPK:INSD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Instadose Pharma's Interest Expense for the three months ended in Feb. 2022 was $0.00 Mil. Its Operating Income for the three months ended in Feb. 2022 was $-0.89 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2022 was $0.07 Mil.

Instadose Pharma's Interest Coverage for the quarter that ended in Feb. 2022 is calculated as

GuruFocus does not calculate Instadose Pharma's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.